(2021)
The Association Between Breastfeeding and Nonalcoholic Fatty Liver Disease in Parous Women: A Nation-wide Cohort Study.
HEPATOLOGY.
74,
6
(2021)
Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY.
33,
1S Suppl 1
(2021)
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials.
GUT AND LIVER.
15,
6
(2021)
Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response.
JOURNAL OF VIRAL HEPATITIS.
28,
10
(2021)
Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy.
HEPATOLOGY INTERNATIONAL.
15,
4
(2021)
Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events.
DIGESTIVE DISEASES AND SCIENCES.
66,
8
(2021)
Predictors and outcome of emergent Liver transplantation for patients with acute-on-chronic liver failure.
DIGESTIVE AND LIVER DISEASE.
53,
8
(2021)
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY.
56,
3
(2021)
A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients.
DIGESTIVE AND LIVER DISEASE.
53,
2
(2021)
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea.
LIVER CANCER.
10,
1
(2021)
Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY.
12,
1
(2021)
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.
YONSEI MEDICAL JOURNAL.
62,
1
(2020)
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria.
ANNALS OF SURGICAL TREATMENT AND RESEARCH.
99,
4
(2020)
Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY.
49,
5
(2020)
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy.
Journal of Liver Cancer.
20,
2
(2020)
Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study.
JOURNAL OF VIRAL HEPATITIS.
27,
9
(2020)
Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-Functional cure unlikely.
JOURNAL OF VIRAL HEPATITIS.
27,
9
(2020)
Hepatitis B reactivation after kidney transplantation in hepatitis B surface antigen-negative, core antibody-positive recipients.
JOURNAL OF VIRAL HEPATITIS.
27,
7
(2020)
Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
HEPATOLOGY.
71,
6
(2020)
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma.
CANCERS.
12,
5
Publications
(2005)
대한소화기학회 총서2. [간염].
군자출판사.
Co-author
(2004)
임상 내과학.
고려의학.
Co-author
(2000)
만성 간질환 환자에서의 영양요법.
일조각.
Co-author
(2000)
신기능 이상과 간신증후군(간경변증).
군자출판사.
Co-author
Conference Paper
(2017)
A Phase 3 Study of TAF (Tenofovir Alafenamide) Compared with TDF(Tenofovir Disoproxil Fumarate) in Patients with HBeAg-negative CHB: Week 48 Results of korea Patients.
KDDW 2017.
KOREA, REPUBLIC OF
(2017)
A Phase 3 Study of TAF (Tenofovir Alafenamide) compa with TDF(Tenofovir Disoprixil Fumarate) in Patients with HBeAg-negative CHB: Week 48 Results of Korea Patients.
KDDW 2017.
KOREA, REPUBLIC OF
(2017)
Clinical Characteristics, Potencial Etiology and Mode of Detection for Non-B Non-C Hepatocellular Carcinoma in Korea.
KDDW 2017.
KOREA, REPUBLIC OF
(2017)
Comparison of Treatment Efficacy between Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) in Treatment-naive Chronic Hepatitis B Patients: Long-term Real-world Experience.
KDDW 2017.
KOREA, REPUBLIC OF
(2015)
Discontinuation of Antiviral prophylaxis in Hepatitis B Virus Infected Patients Who Received Cytotoxic Chemotherapy: Outcomes and Predictors.
AASLD.
UNITED STATES
(2015)
Survival of hepatocellular carcinoma patients according to recommended treatment by the Barcelona Clinic Liver Cancer or Hong Kong Liver Cancer staging system in hepatitis B endemic area.
AASLD.
UNITED STATES
(2015)
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels..
AASLD.
UNITED STATES
(2015)
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels..
AASLD.
UNITED STATES
(2015)
Lamivudine vs. Entecavir for the newly diagnosed hepatitis B-virus related Hepatocellular carcinoma.
AASLD.
UNITED STATES
(2015)
Survival and prognostic factors in patients with intermediate stage hepatocellular carcinoma (HCC) who were treated with repeated transarterial chemoembolization (TACE).
AASLD.
UNITED STATES
(2015)
long term outcome after resection of intermediate hepatocellular carcinoma: comparison to transarterial chemoembolization.
AASLD.
UNITED STATES
(2015)
Cause of death in patients with hepatocellular carcinoma within the Milan criteria.
대한간암학회.
UNITED STATES
(2015)
Combined Radiation Therapy (RT) and Hyperthermia after Trans-catheter Arterial Chemoembolization for Hrpatocellular Carcinoma (HCC) with Portal Vein Tumor Thrombosis (PVTT) : Prospective Phase 2 Trial.
대한간암학회.
UNITED STATES
(2015)
Effect of Oral Antiviral Treatment on Long-Term Outcomes of Radiofrequency Ablation Therapy for Hepatitis B Virus-Related Hepatocellular Carcinoma.
대한간암학회.
UNITED STATES
(2015)
Hwpatocellular Carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low trial load.
대한간암학회.
UNITED STATES
(2015)
Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy: A Matched Study.
대한간암학회.
UNITED STATES
(2014)
Effect of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
AASLD.
UNITED STATES
(2014)
HBV DNA / Quantitative HBsAg level ratio, but not either quantitative HBsAg level or HBV DNA, can predict hepatocellular carcinoma development in HBsAg-nagative chronic hepatitis patients with HBV DNA ≥2000 IU/ml.
AASLD.
UNITED STATES
(2014)
Risk of development of hepatocellular carcinoma in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferse levels.
AASLD.
UNITED STATES
(2014)
The importance of intrahepatic tumor in hepatocellular carcinoma with extrahepatic spread in patients treated with sorafenib.
AASLD.
UNITED STATES